corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library

Items published during the years 2000 to 2009

There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.

Page 144 of 144 pages ‹ First  < 142 143 144

HSL19909
Weir D
Let the Buyer Beware! The New Therapeutic Goods Advertising Code Heralds. Changes in Advertising Medicines.
Health Issues 63 2000 Jun

HSL19920
Metzl J
'Mother's Little Helper': The Crisis of Psychoanalysis and the Miltown Resolution
Gender & History 2003 Aug15:(2):228–255
http://onlinelibrary.wiley.com/doi/10.1111/1468-0424.00300/abstract

HSL19942
Weeks WB, Wallace AE, Kimberly BC
The changing face of pharmaceutical advertising: A look at medical journals reveals a new era in advertising.
Marketing Health Services 2001; 27-30
http://www.ncbi.nlm.nih.gov/pubmed/11525138

HSL19945
Muldoon C.
Pharmaceutical advertising: fact or fiction?
Pharmacoepidemiol Drug Saf 2004; 13:(11):801-2
http://onlinelibrary.wiley.com/doi/10.1002/pds.1011/abstract

HSL19951
Marwick C.
Federal funding for comparative drug studies not in US budget.
BMJ 2004 13; 328:(7440):603
http://www.bmj.com/content/328/7440/603.1?view=long&pmid=15016678

HSL19973
Designing A Prescription Drug Benefit
Health Affairs 2004; 23:(1):123
http://content.healthaffairs.org/content/23/1/123.full

HSL19975
Iglehart JK
An Industry Under Siege Mounts Counterattack
Health Affairs 2004 00 00; 23:(1):7
http://content.healthaffairs.org/content/23/1/7.full

HSL19982
Hindle D.
Are Australia's drugs too cheap for our own good?
Aust Health Rev 2001; 24:(2):4-6
http://www.publish.csiro.au/index.cfm?paper=AH010004

HSL19983
Dalton A.
Australia's pharmaceutical benefits system: flawed but improving, and better than anywhere else.
Aust Health Rev 2001; 24:(2):7-14
www.publish.csiro.au/index.cfm?paper=AH010007

HSL19985
Viney R.
Funding arrangements for pharmaceuticals: can economic evaluation promote efficiency?
Aust Health Rev 2001; 24:(2):21-4
http://www.publish.csiro.au/index.cfm?paper=AH010021

HSL19986
Hartigan-Go K.
The pharmaceutical situation in the Philippines.
Aust Health Rev 2001; 24:(2):25-31
http://www.publish.csiro.au/index.cfm?paper=AH010025

HSL19988
Gilsdorf JR.
As drug marketing pays off, my mother pays up.
Health Aff (Millwood) 2004; 23:(1):208-12
http://content.healthaffairs.org/content/23/1/208.long

HSL19991
Lenzer J.
Stockholders protest Pfizer's drug prices.
CMAJ 2004 6; 171:(1):24
http://www.cmaj.ca/content/171/1/24.2.long

HSL20004
Lexchin J.
The siren call of new drugs.
Expert Rev Pharmacoecon Outcomes Res 2003; 3:(5):513-5
http://www.expert-reviews.com/doi/abs/10.1586/14737167.3.5.513

HSL20025
Lexchin J.
Interactions between doctors and pharmaceutical sales representatives.
Can J Clin Pharmacol 2001; 8:(2):64-5
http://www.ncbi.nlm.nih.gov/pubmed/11493932

HSL20032
Haynes S
Pharma relationship healthy
Medical Observer 2005 Jan15

HSL20041
Goodman B.
All rationalizations large and small.
Am J Bioeth 2003; 3:(3):57-8
http://www.tandfonline.com/doi/abs/10.1162/15265160360706624?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed

HSL20068
Huxhagen K
Pharmacy and Drug Companies - An alliance with some problems
Information to Pharmacists 2003 Sep
http://www.computachem.com.au/i2P/emag/Issue19/Article7.shtml

HSL20087
Siegel L
DTC Advertising: Bane...or Blessing?
Pharmaceutical Executive 2000 Oct140-152
http://business.highbeam.com/137364/article-1G1-66355685/dtc-advertising-bane-blessing

HSL20117
Peters J
Hard to swallow: The high cost of direct-to-consumer advertising.
Minnesota Medicine 2001; 84:
http://www.ncbi.nlm.nih.gov/pubmed/11202520

HSL20121
DTC ads hotly debated
Pharmacy Today 2001 Jan3, 12

HSL20124
Tudiver S
Advertising Prescription Drugs to Consumers: Why women should be wary of direct advertising of drugs
A Friend Indeed 2001 Mar1-3
http://www.straightgoods.ca/ViewConsForum.cfm?REF=259&Cookies=yes

HSL20125
Advertising Prescription Drugs
Which Online 2001

HSL20128
Panckhurst P
Inside the drug wars
AdMedia 2000 July
http://www.archivesearch.co.nz/?webid=adm&articleid=2983

HSL20148
Hollon MF.
Direct-to-consumer advertising: a haphazard approach to health promotion.
JAMA 2005 27; 293:(16):2030-3
http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.293.16.2030

HSL20151
McNee W.
More on DTCA and the cost of asthma inhalers.
N Z Med J 2003 7; 116:(1185):U673
http://www.ncbi.nlm.nih.gov/pubmed/14615811

HSL20152
Griffiths IJ.
Opponents of DTCA need the objectivity they expect of advertisers.
N Z Med J 2003 10; 116:(1183):U641
http://www.ncbi.nlm.nih.gov/pubmed/14581950

HSL20157
Medsafe to report on advert self regulation
Pharmacology Today 2000 Apr8

HSL20158
New legislation
Pharmacy Today 2000 Apr1-2

HSL20160
Medwar C
Because you're worth it
Health Matters Date uncertain 20007

HSL20188
Gönül FF, Carter F, Wind J.
What kind of patients and physicians value direct-to-consumer advertising of prescription drugs.
Health Care Manag Sci 2000; 3:(3):215-26
http://www.ncbi.nlm.nih.gov/pubmed/10907324

HSL20210
Berndt ER, Bhattacharjya A, Mishol DN, Arcelus A, Lasky T.
An analysis of the diffusion of new antidepressants: variety, quality, and marketing efforts.
J Ment Health Policy Econ 2002; 5:(1):3-19
http://www.icmpe.net/fulltext.php?volume=5&page=3&year=2002&num=1&name=Berndt%20ER

HSL20215
Barry HC, Ebell MH, Shaughnessy AF, Slawson DC, Nietzke F.
Family physicians' use of medical abstracts to guide decision making: style or substance?
J Am Board Fam Pract 2001; 14:(6):437-42
http://www.jabfm.org/content/14/6/437.long

HSL20220
Avorn J, Solomon DH.
Cultural and economic factors that (mis)shape antibiotic use: the nonpharmacologic basis of therapeutics.
Ann Intern Med 2000 18; 133:(2):128-35
http://annals.org/article.aspx?volume=133&page=128

HSL20222
Astrup A, Marckmann P, Blundell J.
Oiling of health messages in marketing of food.
Lancet 2000 25; 356:(9244):1786
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2800%2903227-X/fulltext

HSL20267
Buetow S.
What motivates health professionals? Opportunities to gain greater insight from theory.
J Health Serv Res Policy 2007; 12:(3):183-5
http://jhsrp.rsmjournals.com/content/12/3/183.long

HSL20272
Eva KW, Regehr G.
Knowing when to look it up: a new conception of self-assessment ability.
Acad Med 2007; 82:(10):
http://www.ncbi.nlm.nih.gov/pubmed/17895699

HSL20276
Malcolm L, Wright L, Seers M, Davies L, Guthrie J.
Laboratory expenditure in Pegasus Medical Group: a comparison of high and low users of laboratory tests with academics.
N Z Med J 2000 10; 113:(1105):79-81
http://www.ncbi.nlm.nih.gov/pubmed/10855584

HSL20277
'One pill makes you larger...' Don't be seduced by pharmaceutical companies.
Am J Nurs. 2000; 100:(12):7
http://www.ncbi.nlm.nih.gov/pubmed/11202788

HSL20280
O'Toole TP, Kathuria N, Mishra M, Schukart D.
Teaching professionalism within a community context: perspectives from a national demonstration project.
Acad Med 2005 Apr; 80:(4):339-43
http://www.ncbi.nlm.nih.gov/pubmed/15793016

HSL20281
Naylor CD.
The complex world of prescribing behavior.
JAMA 2004 7; 291:(1):104-6
http://www.ncbi.nlm.nih.gov/pubmed/14709583

HSL20285
Nathan DG, Weatherall DJ.
Academic freedom in clinical research.
N Engl J Med 2002 24; 347:(17):1368-71
http://www.nejm.org/doi/full/10.1056/NEJMsb020394

HSL20286
Mukamal KJ, Markson LJ, Flier SR, Calabrese D.
Restocking the sample closet: results of a trial to alter medication prescribing.
J Am Board Fam Pract 2002; 15:(4):285-9
http://www.jabfm.org/content/15/4/285.long

HSL20289
Montori VM, Jaeschke R, Schünemann HJ, Bhandari M, Brozek JL, Devereaux PJ, Guyatt GH.
Users' guide to detecting misleading claims in clinical research reports.
BMJ 2004 6; 329:(7474):1093-6
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC526126/

HSL20290
Miller NM, McGowen RK.
The painful truth: physicians are not invincible.
South Med J 2000; 93:(10):966-73
http://www.ncbi.nlm.nih.gov/pubmed/11147478

HSL20301
Lempp H, Seale C.
The hidden curriculum in undergraduate medical education: qualitative study of medical students' perceptions of teaching.
BMJ 2004 2; 329:(7469):770-3
http://www.bmj.com/content/329/7469/770?view=long&pmid=15459051

HSL20304
Laing R, Hogerzeil H, Ross-Degnan D.
Ten recommendations to improve use of medicines in developing countries.
Health Policy Plan 2001; 16:(1):13-20
http://heapol.oxfordjournals.org/content/16/1/13.long

HSL20307
Klein D, MacDonald A, Drummond N, Cave A.
A qualitative study to identify factors influencing COXIB prescribed by family physicians for musculoskeletal disorders.
Fam Pract 2006; 23:(6):659-65
http://fampra.oxfordjournals.org/content/23/6/659.long

HSL20309
Kerr NL, Tindale RS.
Group performance and decision making.
Annu Rev Psychol 2004; 55:623-55:
http://www.annualreviews.org/doi/abs/10.1146/annurev.psych.55.090902.142009?url_ver=Z39.88-2003&rfr_dat=cr_pub%3Dpubmed&rfr_id=ori%3Arid%3Acrossref.org&journalCode=psych

HSL20310
Kessenich CR.
The garden of good and evil: pharmaceutical companies and the perspective practices of PNPs.
J Pediatr Health Care 2000; 14:(6):324-6
http://www.jpedhc.org/article/S0891-5245%2800%2915370-2/abstract

HSL20311
Kee F, Bickle I.
Critical thinking and critical appraisal: the chicken and the egg?
QJM 2004; 97:(9):609-14
http://qjmed.oxfordjournals.org/content/97/9/609.long

HSL20312
Kassirer JP.
A piece of my mind: financial indigestion.
JAMA 2000 1; 284:(17):2156-7
http://jama.jamanetwork.com/article.aspx?articleid=193234

HSL20316
Hubbard T, Love J.
A new trade framework for global healthcare R&D.
PLoS Biol 2004; 2:(2):E52
http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.0020052

HSL20328
Friedman C, Gatti G, Elstein A, Franz T, Murphy G, Wolf F
Are clinicians correct when they believe they are correct? Implications for medical decision support.
Stud Health Technol Inform 2001; 84:(Pt 1):454-8.
http://booksonline.iospress.nl/Content/View.aspx?piid=27612

HSL20336
Elstein AS, Schwartz A.
Clinical problem solving and diagnostic decision making: selective review of the cognitive literature.
BMJ 2002 23; 324:(7339):729-32
http://www.bmj.com/content/324/7339/729?view=long&pmid=11909793

HSL20339
Edwards W, Fasolo B.
Decision technology.
Annu Rev Psychol 2001; 52:581-606:
http://www.annualreviews.org/doi/abs/10.1146/annurev.psych.52.1.581?url_ver=Z39.88-2003&rfr_dat=cr_pub%3Dpubmed&rfr_id=ori%3Arid%3Acrossref.org&journalCode=psych

HSL20341
Doust J, Del Mar C.
Why do doctors use treatments that do not work? For many reasons - including their inability to stand idle and do nothing
BMJ 2004 28; 328:(7438):474-5
http://www.bmj.com/content/328/7438/474?view=long&pmid=14988163

HSL20344
DiMasi JA, Hansen RW, Grabowski HG.
The price of innovation: new estimates of drug development costs.
J Health Econ 2003; 22:(2):151-85
http://www.sciencedirect.com/science/article/pii/S0167629602001261

HSL20345
Deyo RA.
Gaps, tensions, and conflicts in the FDA approval process: implications for clinical practice.
J Am Board Fam Pract 2004; 17:(2):142-9
http://www.jabfm.org/content/17/2/142.long

HSL20347
Yavas U, Riecken G.
A comparison of medical professionals with favorable and unfavorable attitudes toward advertising: an empirical study.
Health Mark Q 2001; 18:(3-4):13-26
http://www.tandfonline.com/doi/abs/10.1300/J026v18n03_03?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed

HSL20348
Wood W.
Attitude change: persuasion and social influence.
Annu Rev Psychol 2000; 51:539-70:
http://www.annualreviews.org/doi/abs/10.1146/annurev.psych.51.1.539?url_ver=Z39.88-2003&rfr_dat=cr_pub%3Dpubmed&rfr_id=ori%3Arid%3Acrossref.org&journalCode=psych

HSL20349
Wilkes MS, Hoffman JR.
An innovative approach to educating medical students about pharmaceutical promotion.
Acad Med 2001; 76:(12):1271-7
http://pt.wkhealth.com/pt/re/lwwgateway/landingpage.htm;jsessionid=Q2pST3nqdh1K2KKqfnJssTZPgGsTh55TXJkCm2K1TkhgfZLr0hLd!755119086!181195629!8091!-1?issn=1040-2446&volume=76&issue=12&spage=1271

HSL20350
Prosser H, Walley T.
New drug prescribing by hospital doctors: the nature and meaning of knowledge.
Soc Sci Med 2006; 62:(7):1565-78
http://linkinghub.elsevier.com/retrieve/pii/S0277-9536%2805%2900455-7

HSL20351
Shiell A, Chapman S.
The inertia of self-regulation: a game-theoretic approach to reducing passive smoking in restaurants.
Soc Sci Med 2000; 51:(7):1111-9
http://linkinghub.elsevier.com/retrieve/pii/S0277953600000186

HSL20356
Cutts C, Tett SE.
Doctors perceptions of the influences on their prescribing: a comparison of general practitioners based in rural and urban Australia.
Eur J Clin Pharmacol 2003; 58:(11):761-6
http://www.ncbi.nlm.nih.gov/pubmed/12634983

HSL20357
Curtis LH, Østbye T, Sendersky V, Hutchison S, Dans PE, Wright A, Woosley RL, Schulman KA.
Inappropriate prescribing for elderly Americans in a large outpatient population.
Arch Intern Med 2004 9-23; 164:(15):1621-5
http://archinte.jamanetwork.com/article.aspx?articleid=760479

HSL20367
Calvo CB, Rubinstein A.
Influence of new evidence on prescription patterns.
J Am Board Fam Pract 2002; 15:(6):457-62
http://www.jabfm.org/content/15/6/457.long

HSL20369
Britten N, Jenkins L, Barber N, Bradley C, Stevenson F.
Developing a measure for the appropriateness of prescribing in general practice.
Qual Saf Health Care 2003; 12:(4):246-50
http://qualitysafety.bmj.com/content/12/4/246.long

HSL20379
Raisch DW, Troutman WG, Sather MR, Fudala PJ.
Variability in the assessment of adverse events in a multicenter clinical trial.
Clin Ther 2001; 23:(12):2011-20
http://linkinghub.elsevier.com/retrieve/pii/S0149-2918%2801%2980153-3

HSL20382
Ray WA, Stein CM.
Reform of drug regulation--beyond an independent drug-safety board.
N Engl J Med 2006 12; 354:(2):194-201
http://www.nejm.org/doi/full/10.1056/NEJMsb053432

HSL20383
Fugh-Berman A, Scialli AR.
Gynecologists and estrogen: an affair of the heart.
Perspect Biol Med 2006; 49:(1):115-30
http://muse.jhu.edu/journals/perspectives_in_biology_and_medicine/toc/pbm49.1.html

HSL20384
Robertson J, Fryer JL, O'Connell DL, Sprogis A, Henry DA.
The impact of specialists on prescribing by general practitioners.
Med J Aust 2001 15; 175:(8):407-11
http://www.ncbi.nlm.nih.gov/pubmed/11700832

HSL20385
Robertson J, Treloar CJ, Sprogis A, Henry DA
The influence of specialists on prescribing by GPs. A qualitative study.
Aust Fam Physician 2003; 32:(7):573-6.
http://www.ncbi.nlm.nih.gov/pubmed/12901220

HSL20396
Slawson DC, Shaughnessy AF.
Teaching evidence-based medicine: should we be teaching information management instead?
Acad Med 2005; 80:(7):685-9
http://pt.wkhealth.com/pt/re/lwwgateway/landingpage.htm;jsessionid=Q28c5HzQYxKHkZx38Q9rV0XlTy5zLmtnt1lGwXtq1yVNGrNpmmhz!755119086!181195629!8091!-1?issn=1040-2446&volume=80&issue=7&spage=685

HSL20397
Slotnick HB.
How doctors learn: education and learning across the medical-school-to-practice trajectory.
Acad Med 2001; 76:(10):1013-26
http://pt.wkhealth.com/pt/re/lwwgateway/landingpage.htm;jsessionid=Q29D4fLTJ6VL5Zn4PRh16yyQJRrGy5nDN8g3pycncrDQXmdL9ybF!755119086!181195629!8091!-1?issn=1040-2446&volume=76&issue=10&spage=1013

HSL20400
Spiller LD, Wymer WW Jr.
Physicians' perceptions and uses of commercial drug information sources: an examination of pharmaceutical marketing to physicians.
Health Mark Q 2001; 19:(1):91-106
http://www.tandfonline.com/doi/abs/10.1300/J026v19n01_07?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed

HSL20403
Stein P, Valery E.
Competition: an antidote to the high price of prescription drugs.
Health Aff (Millwood) 2004; 23:(4):151-8
http://content.healthaffairs.org/content/23/4/151.long

HSL20404
Steinman MA.
MSJAMA: gifts to physicians in the consumer marketing era.
JAMA 2000 1; 284:(17):2243
http://jama.jamanetwork.com/errors/error.aspx?aspxerrorpath=/article.aspx

HSL20406
Sullivan G, Lansbury GF.
Physiotherapists' use of medications and the influence of drug companies.
Med J Aust 2001 19; 174:(4):200
http://www.ncbi.nlm.nih.gov/pubmed/11270765

HSL20415
Woolf SH, Johnson RE.
The break-even point: when medical advances are less important than improving the fidelity with which they are delivered.
Ann Fam Med 2005; 3:(6):545-52
http://www.annfammed.org/content/3/6/545.long

HSL20419
Dolinski D.
On inferring one's beliefs from one's attempt and consequences for subsequent compliance.
J Pers Soc Psychol 2000; 78:(2):260-72
http://psycnet.apa.org/journals/psp/78/2/260/

HSL20420
Bröder A.
Assessing the empirical validity of the
J Exp Psychol Learn Mem Cogn 2000; 26:(5):1332-46
http://psycnet.apa.org/journals/xlm/26/5/1332/

HSL20425
Winter PL, Sagarin BJ, Rhoads K, Barrett DW, Cialdini RB.
Choosing to Encourage or Discourage: Perceived Effectiveness of Prescriptive Versus Proscriptive Messages.
Environ Manage 2000; 26:(6):589-594
http://www.ncbi.nlm.nih.gov/pubmed/11029110

HSL20427
De Houwer J, Thomas S, Baeyens F.
Associative learning of likes and dislikes: a review of 25 years of research on human evaluative conditioning.
Psychol Bull 2001; 127:(6):853-69
http://psycnet.apa.org/journals/bul/127/6/853/

HSL20529
Mazza D
Why aren't GPs using clinical practice guidelines?
GP Review 2000 Sep4-5

Page 144 of 144 pages ‹ First  < 142 143 144

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.







...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.